Search by Drug Name or NDC
NDC 69238-1539-09 Frovatriptan 2.5 mg/1 Details
Frovatriptan 2.5 mg/1
Frovatriptan is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals NY LLC. The primary component is FROVATRIPTAN SUCCINATE.
MedlinePlus Drug Summary
Frovatriptan is used to treat the symptoms of migraine headaches (severe throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound and light). Frovatriptan is in a class of medications called selective serotonin receptor agonists. It works by narrowing blood vessels around the brain, blocking pain signals from being sent to the brain, and stopping the release of certain natural substances that cause pain, nausea, and other symptoms of migraine. Frovatriptan does not prevent migraine attacks or reduce the number of headaches you have.
Related Packages: 69238-1539-09Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Frovatriptan
Product Information
| NDC | 69238-1539 |
|---|---|
| Product ID | 69238-1539_17108066-165c-4ffa-ac20-53facca9a414 |
| Associated GPIs | 67406030100320 |
| GCN Sequence Number | 048986 |
| GCN Sequence Number Description | frovatriptan succinate TABLET 2.5 MG ORAL |
| HIC3 | H3F |
| HIC3 Description | ANTIMIGRAINE PREPARATIONS |
| GCN | 14977 |
| HICL Sequence Number | 022988 |
| HICL Sequence Number Description | FROVATRIPTAN SUCCINATE |
| Brand/Generic | Generic |
| Proprietary Name | Frovatriptan |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Frovatriptan succinate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | FROVATRIPTAN SUCCINATE |
| Labeler Name | Amneal Pharmaceuticals NY LLC |
| Pharmaceutical Class | Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211292 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69238-1539-09 (69238153909)
| NDC Package Code | 69238-1539-9 |
|---|---|
| Billing NDC | 69238153909 |
| Package | 1 BLISTER PACK in 1 CARTON (69238-1539-9) / 9 TABLET, FILM COATED in 1 BLISTER PACK |
| Marketing Start Date | 2018-11-13 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 6.02896 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | FROVATRIPTAN SUCC 2.5 MG TAB |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |